Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection00:59

Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection

401
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
401
Transcytosis of IgG01:15

Transcytosis of IgG

4.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.0K
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

831
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
831
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

335
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
335
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model01:13

Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model

281
Drugs administered through various routes can lead to nonlinear elimination, resulting in complex pharmacokinetic behaviors crucial to understanding efficacious drug dosing.
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
281
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

225
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
225

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Predictors of Non-Cardiovascular Readmissions in Multimorbid Adults with Heart Failure in Australian Hospitals: A Retrospective Cohort Study.

Journal of clinical medicine·2026
Same author

Indigenous Status and Outcomes in Deep Neck Space Infections: An ICU Cohort Study.

ANZ journal of surgery·2026
Same author

A new first line choice? Has clopidogrel superseded aspirin for secondary prevention following selected minor ischaemic strokes?

Internal medicine journal·2026
Same author

Large language model prompt engineering for medical education: A practical guide for the Australian and New Zealand College of Anaesthetists Final Examination.

Anaesthesia and intensive care·2026
Same author

Pre-implementation safety evaluation of an AI decision-support system for surgical antimicrobial prophylaxis.

Internal medicine journal·2026
Same author

The relationship between time to urgent or emergency pacemaker implantation and entry into residential aged care or death in older adults.

Aging clinical and experimental research·2026

相关实验视频

Updated: Jan 12, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

16.2K

静脉免疫球蛋白断奶评估与零射击的大型语言模型分类.

Emily Burton1,2,3,4, Shrirajh Satheakeerthy2,4, Rudy Goh1,2,3,4

  • 1Lyell McEwin Hospital, Elizabeth Vale, South Australia, Australia.

Transfusion medicine (Oxford, England)
|November 5, 2025
PubMed
概括

一个大型语言模型 (LLM) 在识别适合输入静脉免疫球蛋白 (IVIg) 断奶的患者方面表现出78.6%的准确性. 这种人工智能方法可以帮助优化资源使用并减少与IVIg治疗相关的不良影响.

关键词:
人工智能的人工智能是人工智能.血液制品 血液制品 血液制品慢性炎症性脱髓化的多神经病变.费用 费用 费用 费用 费用 费用多焦点运动神经病变.

更多相关视频

Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.9K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K

相关实验视频

Last Updated: Jan 12, 2026

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

16.2K
Intravenous Injections in Neonatal Mice
05:17

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

60.9K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.9K

科学领域:

  • 神经学 神经学
  • 人工智能在医学中的应用
  • 医疗信息学 医疗信息学

背景情况:

  • 静脉注射免疫球蛋白 (IVIg) 治疗是资源密集型的,并带有潜在的不良影响.
  • 从IVIg中断患者对于优化医疗保健资源利用和降低风险至关重要.

研究的目的:

  • 为了评估大型语言模型 (LLM) 的性能,使用零射击策略来分类与IVIg断奶相关的因素.
  • 评估LLM在识别符合IVIg停药条件的患者的准确性.

主要方法:

  • 对接受定期IVIg的神经科门诊患者进行了一项队列研究.
  • 应用了预先规定的标准来确定IVIg断奶的潜在候选人.
  • 使用LLM来根据这些标准对提取的患者数据进行分类.

主要成果:

  • 在14名确定的患者中,有4名符合可能IVIg断奶的标准.
  • 在对提取的临床笔记采用基于规则的方法时,LLM的整体分类准确率为78.6% (11/14).
  • 据估计,IVIg断奶可以节省84,702.20美元的潜在年度成本.

结论:

  • 需要进一步的研究来确定适合IVIg断奶的患者在不同中心的患病率.
  • 研究LLM可以在多大程度上帮助识别IVIg断奶患者是有必要的.